Clinical Trial Update: Post-transplant Cyclophosphamide in Wiskott-Aldrich Syndrome

View source ↗

Summary

This entry reports an update on a clinical trial evaluating post-transplant cyclophosphamide for patients with Wiskott-Aldrich Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wiskott-aldrich Syndrome

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Capital Research Institute of Pediatrics | Conditions: Wiskott-Aldrich Syndrome | Status: UNKNOWN